1 |
Holtzman DM, Morris JC, Goate AM. Alzheimer's disease: the challenge of the second century [J]. Sci Transl Med, 2011, 3(77): 77sr1.
|
2 |
Mirzaei N, Shi H, Oviatt M, et al. Alzheimer's retinopathy: seeing disease in the eye [J]. Front Neurosci, 2020, 14: 921.
|
3 |
程春芳. 体育锻炼对预防及治疗阿尔兹海默症的影响 [C]//第三届“全民健身 科学运动”学术交流大会论文集, 2021: 87-88.
|
4 |
都梦帆, 胥冰, 郭东艳, 等. 基于Aβ蛋白的阿尔兹海默症的中医药治疗研究进展 [J]. 陕西中医药大学学报, 2022, 45(2): 146-150.
|
5 |
胡慧艳, 任婧楠, 李晓, 等. 嗅闻佛手柑精油对阿尔兹海默症小鼠的神经保护作用研究 [J]. 华中农业大学学报, 2022, 41(1): 229-237.
|
6 |
陈媛, 王珂, 杨敏. 分子影像技术用于视网膜疾病研究进展 [J]. 中国介入影像与治疗学, 2022, 19(5): 314-317.
|
7 |
刘保宏. Aβ蛋白引发阿尔兹海默症发病机制及检测方法的研究进展 [J]. 医学理论与实践, 2021, 34(17): 2959-2961.
|
8 |
常燕, 刘家金, 吴世娜, 等. 18F-THK5317 PET检测不同严重程度阿尔茨海默病患者脑中tau蛋白的分布 [J]. 阿尔茨海默病及相关病杂志, 2019, 2(4): 494-498.
|
9 |
Salobrar-García E, de Hoz R, Ramírez AI, et al. Changes in visual function and retinal structure in the progression of Alzheimer's disease [J]. PloS One, 2019, 14(8): e0220535.
|
10 |
Asanad S, Fantini M, Sultan W, et al. Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline [J]. PloS one, 2020, 15(5): e0232785.
|
11 |
Shi H, Koronyo Y, Rentsendorj A, et al. Retinal vasculopathy in Alzheimer's disease [J]. Front Neurosci, 2021, 15: 731614.
|
12 |
赵俊一, 钟伟聪, 邓云松, 等. 阿尔茨海默病中Tau蛋白与线粒体损伤 [J]. 生命科学研究, 2020, 24(1): 55-61.
|
13 |
孙国婧, 阿怀全, 胡雪婵. 阿尔兹海默症患者语用能力蚀失特点研究 [J]. 应用语言学与语言康复, 2022, 20(4): 314-316.
|
14 |
Hart NJ, Koronyo Y, Black KL, et al. Ocular indicators of Alzheimer’s: exploring disease in the retina [J]. Acta Neuropathol, 2016, 132(6): 767-787.
|
15 |
Mahajan D, Votruba M. Can the retina be used to diagnose and plot the progression of Alzheimer's disease? [J]. Acta Ophthalmol, 2017, 95(8): 768-777.
|
16 |
Ashok A, Singh N, Chaudhary S, et al. Retinal degeneration and Alzheimer's disease: an evolving link [J]. Int J Mol Sci, 2020, 21(19): 7290.
|
17 |
Donix M, Wittig D, Hermann W, et al. Relation of retinal and hippocampal thickness in patients with amnestic mild cognitive impairment and healthy controls [J]. Brain Behav, 2021, 11(5): e02035.
|
18 |
Moschos MM, Markopoulos I, Chatziralli I, et al. Structural and functional impairment of the retina and optic nerve in Alzheimer's disease [J]. Curr Alzheimer Res, 2012, 9(7): 782-800.
|
19 |
Sen S, Saxena R, Vibha D, et al. Detection of structural and electrical disturbances in macula and optic nerve in Alzheimer's patients and their correlation with disease severity [J]. Semin Ophthalmol, 2020, 35(2): 116-125.
|
20 |
Carelli V, La Morgia C, Ross-Cisneros FN, et al. Optic neuropathies: the tip of the neurodegeneration iceberg [J]. Hum Mol Genet, 2017, 26(R2): 139-150.
|
21 |
Chalkias E, Topouzis F, Tegos T, et al. The contribution of ocular biomarkers in the differential diagnosis of Alzheimer's disease versus other types of dementia and future prospects [J]. J Alzheimers Dis, 2021, 80(2): 493-504.
|
22 |
Bao W, Jia H, Finnema S, et al. PET imaging for early detection of Alzheimer's disease: from pathologic to physiologic biomarkers [J]. PET Clin, 2017, 12(3): 329-350.
|
23 |
王思懿, 李现想, 刘宜周, 等. 阿尔茨海默症治疗药物现状及展望 [J]. 神经药理学报, 2020, 10(5): 38-42.
|
24 |
宋博雅. 阿尔兹海默症发病机制的研究进展 [J]. 西安文理学院学报(自然科学版), 2020, 23(4): 77-92.
|
25 |
王嘉凡, 陈松, 高向东. 阿尔兹海默症靶点及相关药物研究进展 [J]. 药物生物技术, 2021, 28(3): 323-330.
|
26 |
Ramirez AI, de Hoz R, Salobrar-Garcia E, et al. The role of microglia in retinal neurodegeneration: Alzheimer's disease, parkinson, and glaucoma [J]. Front Aging Neurosci, 2017, 9: 214.
|
27 |
蔡雅文, 柴玉慧, 缪明星, 等. 细胞焦亡介导的阿尔兹海默症发病机制研究进展 [J]. 中国药学杂志, 2021, 56(21): 1701-1705.
|
28 |
杨浩池, 张海英, 张云霞, 等. 干细胞治疗阿尔兹海默病的研究现状 [J]. 海南医学院学报, 2020, 26(11): 876-880.
|
29 |
李莹, 钱美齐, 邱雪. 阿尔兹海默症生物标志物和早期诊断新技术 [J]. 分析测试学报, 2022, 41(4): 553-561.
|
30 |
Moreno-Ramos T, Benito-León J, Villarejo A, et al. Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease [J]. J Alzheimers Dis, 2013, 34(3): 659-664.
|